European Journal of Medicinal Chemistry · 2020 · 42 citations · 14 references
MedicineOncologyPharmacologyApoptosisCancer PharmacologyMolecular OncologyPharmacodynamics Of Anticancer AgentsTargeted Cancer TherapyTargeted TherapyTopoisomerase InhibitorsDna Damage Response InhibitorsDna Damage Response TargetingDna Damage-induced Cell DeathParp InhibitionPoly Adp-ribose Polymerase InhibitorsTriple-negative Breast Cancer Therapy
14
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Hannah Farmer, Nuala McCabe, Christopher J. Lord et al. · Nature · 2005 · 6.7K citations
UCSF ChimeraX: Meeting modern challenges in visualization and analysis
Thomas D. Goddard, Conrad C. Huang, Elaine C. Meng et al. · Protein Science · 2017 · 5.8K citations · Full text
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Helen E. Bryant, Niklas Schultz, Huw D. Thomas et al. · Nature · 2005 · 5.2K citations